Advertisement
Canada markets close in 3 hours 51 minutes

  • S&P/TSX

    21,825.50
    -48.22 (-0.22%)
     

  • S&P 500

    5,022.78
    -48.85 (-0.96%)
     

  • DOW

    37,927.69
    -533.23 (-1.39%)
     

  • CAD/USD

    0.7304
    +0.0006 (+0.08%)
     

  • CRUDE OIL

    82.57
    -0.24 (-0.29%)
     

  • Bitcoin CAD

    87,915.48
    -805.49 (-0.91%)
     

  • CMC Crypto 200

    1,386.89
    +4.32 (+0.31%)
     

  • GOLD FUTURES

    2,342.60
    +4.20 (+0.18%)
     

  • RUSSELL 2000

    1,966.66
    -28.77 (-1.44%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ

    15,498.28
    -214.47 (-1.36%)
     

  • VOLATILITY

    16.68
    +0.71 (+4.45%)
     

  • FTSE

    8,078.86
    +38.48 (+0.48%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6810
    -0.0009 (-0.13%)
     
MARKETS LIVE BLOG:

STOCKS SLIDE AFTER META'S REALITY CHECK, WITH GDP ON DECK

Owner of Facebook and Instagram plans to spend up to US$10B on AI infrastructure investments

U.S. administers 417.8 million doses of COVID-19 vaccines - CDC

Reuters
·1 min read
FILE PHOTO: A syringe is filled with a dose of Pfizer's coronavirus disease (COVID-19) vaccine at a pop-up community vaccination center in Valley Stream, New York

(Reuters) - The United States has administered 417,795,537 doses of COVID-19 vaccines in the country as of Thursday morning and distributed 510,735,525 doses, the U.S. Centers for Disease Control and Prevention said.

Those figures are up from the 416,154,424 vaccine doses the CDC said had gone into arms by Oct. 27 out of 507,637,305 doses delivered.

The agency said 221,348,530 people had received at least one dose while 191,242,432 people were fully vaccinated as of 6:00 a.m. ET on Thursday.

The CDC tally includes two-dose vaccines from Moderna and Pfizer/BioNTech, as well as Johnson & Johnson's one-shot vaccine.

ADVERTISEMENT

About 15.4 million people have received a booster dose of either Pfizer, Moderna or Johnson & Johnson's COVID-19 vaccine. Booster doses from Moderna and Johnson & Johnson were authorized by the U.S. health regulator on Oct. 20.

(Reporting by Amruta Khandekar in Bengaluru; Editing by Aditya Soni)